Recent Examples on the WebOf the 182 participants who had an evaluable nasopharyngeal swab, 78 showed detectable virus levels at the baseline. Chris Smith, BGR, 8 Mar. 2021 With 30 myelofibrosis patients now treated and evaluable in its mid-stage study, the 24-week spleen response rate to CPI-0610 — when used on top of Incyte’s market-leading drug Jakafi — stands at 63%. Adam Feuerstein, STAT, 12 June 2020